Boston, MA (PRWEB) March 24, 2014
David J. Dykeman, co-chair of Greenberg Traurig’s Global Life Sciences & Medical Technology Group, will be a featured speaker at the Q1 Pharmaceutical and Medical Device Legal and Compliance Forum on March 24-25, 2014 in Alexandria, Virginia.
Dykeman will speak on the “Impact of Patent Reform in U.S. and Europe on Life Science Business Operations” on Monday, March 24, 2014 from 1:30 – 2:45 p.m. This session will provide valuable insights into the America Invents Act (AIA) and Europe’s Unitary Patent and Unified Patent Court, and how life science and medical technology companies can best protect and enforce their drug and device innovations.
Specific topics include:
Key initiatives under the AIA and Europe’s Unitary Patent and Unified Patent Court
Strategies to best protect medical products
Patent application timelines under US patent reform
Considerations for deciding whether to file for Unitary Patent, European Patent Office, or national patent applications
Impact of Patent Trolls on drug and device companies
A registered patent attorney with over 18 years of experience in patents, intellectual property, and licensing, Dykeman focuses his practice on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in medical devices, life sciences, biotechnology and healthcare IT. In 2012, Dykeman was appointed the founding co-chair of the ABA Section of Science & Technology Law's Medical Device Committee. He serves on the Board of Directors of the Massachusetts Medical Device Industry Council (MassMEDIC), and on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine.
An author of over 45 articles and a speaker at over 40 conferences on medical devices and life sciences intellectual property, Dykeman was honored as one of “40 Medtech Innovators Under 40” by MD+DI Magazine, and was named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.
About the Q1 Pharmaceutical & Medical Device Legal Forum
The Q1 Pharmaceutical & Medical Device Legal Forum will provide attendees with an opportunity to participate in a two-day program that will cover a wide spectrum of the important legal considerations faced by today’s marketplace. With topics focusing on Litigation, IP/Patent Protection as well as Corporate Legal, attendees will have ample opportunity to discuss the myriad challenges faced by these highly regulated industries. Throughout the two days, the focus will also highlight technologies and solutions that can enable corporations to more quickly address legal issues, streamlining procedures and ultimately ensuring positive litigation outcomes, at reduced costs.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 1750 attorneys serving clients from 36 offices in the United States, Latin America, Europe, the Middle East and Asia Greenberg Traurig is among the Top 10 law firms on The National Law Journal's 2013 NLJ 350, an annual ranking of the largest firms in the U.S. For additional information, please visit http://www.gtlaw.com.